NASDAQ$CTMX
CytomX Therapeutics Inc · Q1 2024 earnings
Q1 2024 earnings ·
Briefing
CTMX Q1 2024 — $4.0M revenue
Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results express. CytomX Therapeutics Inc reported Q1 2024 results. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $4.0M.
- Filed on Form 10-Q (accession 0000950170-24-055588).
Headline financials
Revenue & EPS history
CytomX Therapeutics Inc · Revenue · Quarterly
$41.5M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2024
+3.6%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+2.5%
Avg return
30 days after
53%
16 / 30 earnings
Positive
+129.5%
Q1 2025
Best reaction
-19.3%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -3.4% | -6.3% | -27.8% | |
| Q4 2025 | -19.3% | -34.1% | -27.6% | |
| Q3 2025 | -0.5% | -2.6% | -6.2% | |
| Q1 2025 | +129.5% | +118.8% | +203.9% | |
| Q3 2024 | +0.0% | +4.0% | +18.0% | |
| Q2 2024 | +1.7% | +0.0% | +3.4% | |
| Q1 2024 | +2.9% | -53.6% | -59.7% | |
| Q3 2023 | +0.8% | -7.9% | +15.0% | |
| Q2 2023 | -0.6% | -1.2% | -18.8% | |
| Q1 2023 | +2.4% | +6.0% | +3.6% | |
| Q3 2022 | -1.6% | +3.2% | +29.6% | |
| Q2 2022 | +3.8% | +1.9% | -7.0% | |
| Q1 2022 | -5.8% | +4.1% | +4.1% | |
| Q3 2021 | -2.0% | +14.8% | +8.4% | |
| Q2 2021 | +3.8% | -12.0% | -7.9% | |
| Q1 2021 | -4.5% | -4.5% | -20.6% | |
| Q3 2020 | +0.0% | +5.7% | +4.7% | |
| Q2 2020 | +1.3% | -6.2% | -11.9% | |
| Q1 2020 | +1.7% | +21.5% | -33.1% | |
| Q3 2019 | +0.8% | -9.8% | +3.1% | |
| Q2 2019 | +2.6% | -7.3% | -19.9% | |
| Q1 2019 | -0.1% | +7.2% | +3.4% | |
| Q3 2018 | -8.8% | +7.3% | -1.1% | |
| Q2 2018 | +1.6% | -4.2% | -19.4% | |
| Q1 2018 | +0.9% | -3.6% | +2.2% | |
| Q3 2017 | -1.7% | -1.4% | +0.4% | |
| Q2 2017 | +0.2% | +2.6% | +23.1% | |
| Q1 2017 | +2.3% | -0.2% | -2.3% | |
| Q3 2016 | -2.8% | -5.7% | -2.3% | |
| Q2 2016 | +3.2% | +10.8% | +19.0% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro